Status:
COMPLETED
THRA_hematologic Variables
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Avascular Necrosis of Hip
Eligibility:
All Genders
20-80 years
Brief Summary
Total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables an...
Eligibility Criteria
Inclusion
- avascular necrosis of hip
- total hip replacement arthroplasty
Exclusion
- revision operation
- hematologic disease
- anticoagulant medication
- preoperative hemoglobin \< 10 g/dl
- preoperative transfusion of red blood cells
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT01521858
Start Date
January 1 2012
End Date
February 1 2013
Last Update
August 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam, Gyounggi, South Korea, 463-707